Literature DB >> 9531976

Presence of laminin fragments in cyst fluid from patients with autosomal dominant polycystic kidney disease (ADPKD): role in proliferation of tubular epithelial cells.

M J Slade1, R B Kirby, I Pócsi, J K Jones, R G Price.   

Abstract

Cyst fluid samples obtained from eight patients with autosomal dominant polycystic kidney disease (ADPKD) were analysed for the presence of the basement membrane component laminin and its breakdown products, using ELISA and immunoblotting techniques. Whole laminin was not detected, whereas laminin fragments of 270, 155, 87, 56, and 14 kDa were detected at a mean total value of approximately 0.5 microgram/ml. The laminin fragments were assessed for their effect on cultured normal and ADPKD epithelial cells. Both cell types showed accelerated growth under these conditions. These findings suggest that basement membrane degradative fragments present in cyst fluid may contribute to cystic epithelial cell proliferation and may therefore be important in the pathogenesis of ADPKD.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9531976     DOI: 10.1016/s0167-4889(97)00125-0

Source DB:  PubMed          Journal:  Biochim Biophys Acta        ISSN: 0006-3002


  3 in total

1.  Characterization of the renal cyst fluid proteome in autosomal dominant polycystic kidney disease (ADPKD) patients.

Authors:  Xianyin Lai; Robert L Bacallao; Bonnie L Blazer-Yost; David Hong; Stephen B Mason; Frank A Witzmann
Journal:  Proteomics Clin Appl       Date:  2008-07-01       Impact factor: 3.494

2.  Beta4 integrin and laminin 5 are aberrantly expressed in polycystic kidney disease: role in increased cell adhesion and migration.

Authors:  Dominique Joly; Viviane Morel; Aurélie Hummel; Antonella Ruello; Patrick Nusbaum; Natacha Patey; Laure-Hélène Noël; Patricia Rousselle; Bertrand Knebelmann
Journal:  Am J Pathol       Date:  2003-11       Impact factor: 4.307

3.  Protective Effects of Bu-Shen-Huo-Xue Formula against 5/6 Nephrectomy-Induced Chronic Renal Failure in Rats.

Authors:  Jian-Rao Lu; Hai-Yan Han; Jie Chen; Chong-Xiang Xiong; Xin-Hua Wang; Jing Hu; Xiu-Feng Chen; Li Ma
Journal:  Evid Based Complement Alternat Med       Date:  2014-04-29       Impact factor: 2.629

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.